Results
eNauka >
Results >
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study
| Title: | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study | Authors: | Hart Lowel L; Ferrarotto Renata; Andrić Zoran G   ; Beck Thaddeus J; Subramanian Janakiraman; Radosavljević Davorin Z ; Zarić Bojan ; Hanna Wahid T; Aljumaily Raid; Owonikoko Taofeek K; |
Issue Date: | 2020 | Publication: | ADVANCES IN THERAPY | ISSN: | 0741-238X Advances in Therapy Search Idenfier |
Publisher: | Springer | Type: | Article | Collation: | vol. 38 br. 1 str. 350-365 | DOI: | 10.1007/s12325-020-01538-0 | WoS-ID: | 000582826000001 | Scopus-ID: | 2-s2.0-85094653176 | PMID: | 33123968 | PMCID: | PMC7854399 | URI: | https://zenodo.org/record/4709814 https://enauka.gov.rs/handle/123456789/597482 |
Project: | url:https://static-content.springer.com/esm/art%3A10.1007%2Fs12325-020-01538-0/MediaObjects/12325_2020_1538_MOESM3_ESM.docx pmcid:PMC7854399 doi:10.6084/ m9.figshare.13078844. |
M-category: | 21M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.